SCHEMBL7197080

SCHEMBL7197080

COC(=O)C(C)(O)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.48
PIK3CD O00329 1/20 0.37
TSHR P16473 3/20 0.35
SRC P12931 1/20 0.34
ALDH1A1 P00352 4/20 0.33
CA14 Q9ULX7 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KCNN4 O15554 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
MMP8 P22894 1/20 0.31
POLB P06746 1/20 0.30
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20959675 0.84 DGAT1 (0.39) DGAT1PIK3CDSRCALDH1A1SMN1; SMN2
SCHEMBL28846502 0.78 DGAT1 (0.42) DGAT1PIK3CDSRCALDH1A1CA14
SCHEMBL16501325 0.78 DGAT1 (0.48) DGAT1PIK3CDSRCALDH1A1CA14
SCHEMBL1629800 0.78 DGAT1 (0.48) DGAT1PIK3CDSRCALDH1A1CA14
SCHEMBL21811154 0.76 DGAT1 (0.46) DGAT1PIK3CDALDH1A1CA14SMN1; SMN2
SCHEMBL28550395 0.75 DGAT1 (0.37) DGAT1TSHRSRCALDH1A1KCNN4
SCHEMBL606621 0.75 DGAT1 (0.37) DGAT1TSHRSRCALDH1A1KCNN4
SCHEMBL18832142 0.75 DGAT1 (0.37) DGAT1TSHRSRCALDH1A1KCNN4
SCHEMBL28918161 0.74 DGAT1 (0.44) DGAT1TSHRSRCALDH1A1CA14
SCHEMBL234272 0.74 DGAT1 (0.44) DGAT1TSHRSRCALDH1A1CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116062730-A Preparation method of pre-lithiated silicon-based composite material, pre-lithiated silicon-based composite material and application thereof 胜华新材料科技(眉山)有限公司 2023-05-05 CN claimed
CN-116062730-A Preparation method of pre-lithiated silicon-based composite material, pre-lithiated silicon-based composite material and application thereof 胜华新材料科技(眉山)有限公司 2023-05-05 CN disclosed
CN-111172545-B Photo-anode of ionic liquid modified semiconductor composite film and preparation method thereof 中国科学院海洋研究所 2022-03-08 CN disclosed
CN-111172545-A Photo-anode of ionic liquid modified semiconductor composite film and preparation method thereof 中国科学院海洋研究所 2020-05-19 CN disclosed
CN-102681344-A Photosensitive resin composition, low dielectric constant light shielding layer and liquid crystal display apparatus using the same ROHM & HAAS ELECT MAT 2012-09-19 CN disclosed
US-6583312-B2 Catalytic hydrogenation of trimethylpyruvic acid BAYER AKTIENGESELLSCHAFT (DE) 2003-06-24 US disclosed
US-20020035271-A1 Process for preparing oprtically active trimethyllactic acid and its ester BAYER AKTIENGESELLSCHAFT (DE) 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035271-A1 Process for preparing oprtically active trimethyllactic acid and its ester ME1, OPRK1, OPRM1 DGAT1 1757/4885PIK3CD 67/4885TSHR 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.